These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33453249)

  • 21. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knockdown of thioredoxin-interacting protein ameliorates high glucose-induced epithelial to mesenchymal transition in renal tubular epithelial cells.
    Wei J; Shi Y; Hou Y; Ren Y; Du C; Zhang L; Li Y; Duan H
    Cell Signal; 2013 Dec; 25(12):2788-96. PubMed ID: 24041652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycogen synthase kinase‑3β is required for epithelial‑mesenchymal transition and barrier dysfunction in mouse podocytes under high glucose conditions.
    Guo J; Yang L; Qiao Y; Liu Z
    Mol Med Rep; 2016 Nov; 14(5):4091-4098. PubMed ID: 27748847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent Insulin Resistance in Podocytes Caused by Epigenetic Changes of SHP-1 in Diabetes.
    Lizotte F; Denhez B; Guay A; Gévry N; Côté AM; Geraldes P
    Diabetes; 2016 Dec; 65(12):3705-3717. PubMed ID: 27585521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Extract of Ginkgo biloba and alpha-lipoic acid attenuate advanced glycation end products accumulation and RAGE expression in diabetic nephropathy rats].
    Li XZ; Yan HD; Wang J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2011 Apr; 31(4):525-31. PubMed ID: 21608227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II-mediated MYH9 downregulation causes structural and functional podocyte injury in diabetic kidney disease.
    Kang JS; Lee SJ; Lee JH; Kim JH; Son SS; Cha SK; Lee ES; Chung CH; Lee EY
    Sci Rep; 2019 May; 9(1):7679. PubMed ID: 31118506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TXNIP deficiency mitigates podocyte apoptosis via restraining the activation of mTOR or p38 MAPK signaling in diabetic nephropathy.
    Song S; Qiu D; Wang Y; Wei J; Wu H; Wu M; Wang S; Zhou X; Shi Y; Duan H
    Exp Cell Res; 2020 Mar; 388(2):111862. PubMed ID: 31982382
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shifts in podocyte histone H3K27me3 regulate mouse and human glomerular disease.
    Majumder S; Thieme K; Batchu SN; Alghamdi TA; Bowskill BB; Kabir MG; Liu Y; Advani SL; White KE; Geldenhuys L; Tennankore KK; Poyah P; Siddiqi FS; Advani A
    J Clin Invest; 2018 Jan; 128(1):483-499. PubMed ID: 29227285
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Advanced glycation end products induce the apoptosis of and inflammation in mouse podocytes through CXCL9-mediated JAK2/STAT3 pathway activation.
    Yu J; Wu H; Liu ZY; Zhu Q; Shan C; Zhang KQ
    Int J Mol Med; 2017 Oct; 40(4):1185-1193. PubMed ID: 28849106
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Critical role of serum response factor in podocyte epithelial-mesenchymal transition of diabetic nephropathy.
    Zhao L; Wang X; Sun L; Nie H; Liu X; Chen Z; Guan G
    Diab Vasc Dis Res; 2016 Jan; 13(1):81-92. PubMed ID: 26408645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Klotho plays a protective role against glomerular hypertrophy in a cell cycle-dependent manner in diabetic nephropathy.
    Oh HJ; Nam BY; Wu M; Kim S; Park J; Kang S; Park JT; Yoo TH; Kang SW; Han SH
    Am J Physiol Renal Physiol; 2018 Oct; 315(4):F791-F805. PubMed ID: 29638159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epithelial-mesenchymal transition as a potential explanation for podocyte depletion in diabetic nephropathy.
    Yamaguchi Y; Iwano M; Suzuki D; Nakatani K; Kimura K; Harada K; Kubo A; Akai Y; Toyoda M; Kanauchi M; Neilson EG; Saito Y
    Am J Kidney Dis; 2009 Oct; 54(4):653-64. PubMed ID: 19615802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes.
    Teng B; Schroder P; Müller-Deile J; Schenk H; Staggs L; Tossidou I; Dikic I; Haller H; Schiffer M
    Diabetes; 2016 Dec; 65(12):3667-3679. PubMed ID: 27531950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes of podocyte p130Cas in diabetic conditions.
    Ha TS; Choi JY; Park HY; Han GD
    J Nephrol; 2013; 26(5):870-6. PubMed ID: 23559070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
    Yuan Y; Sun H; Sun Z
    Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sulodexide Protects Renal Tubular Epithelial Cells from Oxidative Stress-Induced Injury via Upregulating Klotho Expression at an Early Stage of Diabetic Kidney Disease.
    Liu YN; Zhou J; Li T; Wu J; Xie SH; Liu HF; Liu Z; Park TS; Wang Y; Liu WJ
    J Diabetes Res; 2017; 2017():4989847. PubMed ID: 28929120
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.
    Stieger N; Worthmann K; Teng B; Engeli S; Das AM; Haller H; Schiffer M
    Metabolism; 2012 Aug; 61(8):1073-86. PubMed ID: 22365040
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apelin inhibited epithelial-mesenchymal transition of podocytes in diabetic mice through downregulating immunoproteasome subunits β5i.
    Yin J; Wang Y; Chang J; Li B; Zhang J; Liu Y; Lai S; Jiang Y; Li H; Zeng X
    Cell Death Dis; 2018 Oct; 9(10):1031. PubMed ID: 30301930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GSK-3β inhibitor attenuates urinary albumin excretion in type 2 diabetic db/db mice, and delays epithelial-to-mesenchymal transition in mouse kidneys and podocytes.
    Wan J; Li P; Liu DW; Chen Y; Mo HZ; Liu BG; Chen WJ; Lu XQ; Guo J; Zhang Q; Qiao YJ; Liu ZS; Wan GR
    Mol Med Rep; 2016 Aug; 14(2):1771-84. PubMed ID: 27357417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic regulation of the thioredoxin-interacting protein (TXNIP) gene by hyperglycemia in kidney.
    De Marinis Y; Cai M; Bompada P; Atac D; Kotova O; Johansson ME; Garcia-Vaz E; Gomez MF; Laakso M; Groop L
    Kidney Int; 2016 Feb; 89(2):342-53. PubMed ID: 26806835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.